CanSino Biologics Inc. (688185.SS)

CNY 56.85

(4.33%)

EBITDA Summary of CanSino Biologics Inc.

  • CanSino Biologics Inc.'s latest annual EBITDA in 2023 was -1.64 Billion CNY , down -49.3% from previous year.
  • CanSino Biologics Inc.'s latest quarterly EBITDA in 2024 Q3 was 18.22 Million CNY , down -21.44% from previous quarter.
  • CanSino Biologics Inc. reported an annual EBITDA of -945.81 Million CNY in 2022, down -152.06% from previous year.
  • CanSino Biologics Inc. reported an annual EBITDA of 2.04 Billion CNY in 2021, up 590.61% from previous year.
  • CanSino Biologics Inc. reported a quarterly EBITDA of -16.54 Million CNY for 2024 Q2, up 125.59% from previous quarter.
  • CanSino Biologics Inc. reported a quarterly EBITDA of 18.22 Million CNY for 2024 Q3, down -21.44% from previous quarter.

Annual EBITDA Chart of CanSino Biologics Inc. (2023 - 2016)

Historical Annual EBITDA of CanSino Biologics Inc. (2023 - 2016)

Year EBITDA EBITDA Growth
2023 -1.64 Billion CNY -49.3%
2022 -945.81 Million CNY -152.06%
2021 2.04 Billion CNY 590.61%
2020 -364.68 Million CNY -192.11%
2019 -134.24 Million CNY 0.62%
2018 -126.26 Million CNY -104.82%
2017 -55.93 Million CNY -50.17%
2016 -47.96 Million CNY 0.0%

Peer EBITDA Comparison of CanSino Biologics Inc.

Name EBITDA EBITDA Difference
Hubei Jumpcan Pharmaceutical Co., Ltd. 3.61 Billion CNY 145.523%
Yabao Pharmaceutical Group Co., Ltd 391.76 Million CNY 520.33%
Shandong Lukang Pharmaceutical Co.,Ltd. 741.88 Million CNY 321.962%
Zhejiang Huahai Pharmaceutical Co., Ltd. 2.15 Billion CNY 176.399%
Chongqing Taiji Industry(Group) Co.,Ltd 1.6 Billion CNY 202.787%
Tasly Pharmaceutical Group Co., Ltd 1.95 Billion CNY 184.251%
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited 971.82 Million CNY 269.444%
Lionco Pharmaceutical Group Co.,Ltd. -90.79 Million CNY -1713.742%
Joincare Pharmaceutical Group Industry Co.,Ltd. 5.01 Billion CNY 132.847%
Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. 111.25 Million CNY 1580.143%
Shanghai Haoyuan Chemexpress Co., Ltd. 275.11 Million CNY 698.548%
China Animal Husbandry Industry Co., Ltd. 677.63 Million CNY 343.008%
Jiangsu Kanion Pharmaceutical Co.,Ltd. 743.16 Million CNY 321.58%
Zhejiang Jiuzhou Pharmaceutical Co., Ltd 1.59 Billion CNY 203.094%
Zhejiang Shengda Bio-Pharm Co., Ltd. 34.44 Million CNY 4880.118%
Harbin Pharmaceutical Group Co., Ltd. 1.02 Billion CNY 260.751%
Zhejiang Medicine Co., Ltd. 1.13 Billion CNY 244.92%
HPGC Renmintongtai Pharmaceutical Corporation 474.3 Million CNY 447.183%
Humanwell Healthcare (Group) Co.,Ltd. 4.55 Billion CNY 136.124%
Ginwa Enterprise (Group) Inc. -3.67 Million CNY -44705.461%
Tianjin Tianyao Pharmaceuticals Co., Ltd. 479.02 Million CNY 443.763%
KPC Pharmaceuticals, Inc. 801.81 Million CNY 305.372%
Henan Lingrui Pharmaceutical Co., Ltd. 736.53 Million CNY 323.576%
Jiangsu Jibeier Pharmaceutical Co., Ltd. 265.55 Million CNY 720.106%
Ningbo Menovo Pharmaceutical Co., Ltd. 155.45 Million CNY 1159.31%
Nanjing Well Pharmaceutical Group Co.,Ltd. 209.72 Million CNY 885.177%
Guizhou Yibai Pharmaceutical Co., Ltd. 355.07 Million CNY 563.767%
Zhongzhu Healthcare Holding Co.,Ltd -234.13 Million CNY -603.328%
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited 6.45 Billion CNY 125.499%
China National Medicines Corporation Ltd. 2.82 Billion CNY 158.272%
Shenzhen Chipscreen Biosciences Co., Ltd. 187.43 Million CNY 978.524%
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. 186.48 Million CNY 983.002%
Jianmin Pharmaceutical Group Co.,Ltd. 615.11 Million CNY 367.706%
Beijing Tongrentang Co., Ltd 4.09 Billion CNY 140.182%
North China Pharmaceutical Company Ltd. 1.51 Billion CNY 208.511%
China Resources Double-Crane Pharmaceutical Co.,Ltd. 2.21 Billion CNY 174.191%
Zhejiang Hisun Pharmaceutical Co., Ltd. 1.18 Billion CNY 239.518%
Heilongjiang ZBD Pharmaceutical Co., Ltd. 840.85 Million CNY 295.836%
ChengDu ShengNuo Biotec Co.,Ltd. 121.76 Million CNY 1452.416%
Dali Pharmaceuticalco.,Ltd 360.83 Thousand CNY 456465.783%
Tibet Weixinkang Medicine Co., Ltd. 266.6 Million CNY 717.655%
Changchun BCHT Biotechnology Co. 662.93 Million CNY 348.397%
Shanghai Jiaoda Onlly Co.,Ltd 17.57 Million CNY 9467.777%
Jiang Zhong Pharmaceutical Co.,Ltd 1.03 Billion CNY 259.844%
Mayinglong Pharmaceutical Group Co., LTD. 633.25 Million CNY 360.04%
Cisen Pharmaceutical Co., Ltd. 840.03 Million CNY 296.029%
Zhejiang Cheng Yi Pharmaceutical Co., Ltd. 267.44 Million CNY 715.721%
Hunan Warrant Pharmaceutical Co.,Ltd 292.03 Million CNY 663.866%
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. 5.55 Billion CNY 129.62%
Hunan Fangsheng Pharmaceutical Co., Ltd. 310.08 Million CNY 631.042%
Guangxi Wuzhou Zhongheng Group Co.,Ltd 348.84 Million CNY 572.044%
Guobang Pharma Ltd. 1.04 Billion CNY 258.129%
Shaanxi Kanghui Pharmaceutical Co., Ltd. 3.22 Million CNY 51084.552%
Shandong Buchang Pharmaceuticals Co., Ltd. 1.09 Billion CNY 250.217%
Zhejiang Starry Pharmaceutical Co.,Ltd. 327.5 Million CNY 602.795%
Kangmei Pharmaceutical Co., Ltd. 536.71 Million CNY 406.809%
Henan Taloph Pharmaceutical Stock Co.,Ltd 111.8 Million CNY 1572.794%
ZhuZhou QianJin Pharmaceutical Co.,Ltd 565.74 Million CNY 391.07%
Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd -57.84 Million CNY -2746.786%
Beijing Sun-Novo Pharmaceutical Research Co., Ltd. 250.5 Million CNY 757.356%
Shanghai Shyndec Pharmaceutical Co., Ltd. 1.97 Billion CNY 183.244%
Shanghai Yizhong Pharmaceutical Co., Ltd. 195.4 Million CNY 942.727%
Tibet Rhodiola Pharmaceutical Holding Co. 976.16 Million CNY 268.692%
Sichuan Huiyu Pharmaceutical Co., Ltd. 203.49 Million CNY 909.206%
Jiangsu Lianhuan Pharmaceutical Co., Ltd. 259.87 Million CNY 733.643%